Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 30 April 2024
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 30 April 2024. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): Consolidated NAV per share (excluding Revaluation Surplus) was Tk. 85.21 as on March 31, 2024 and Tk. 81.15 as on June 30, 2023. NAV per share (including Revaluation Surplus) was Tk. 93.01 as on March 31, 2024 and Tk. 88.99 as on June 30, 2023. (end)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(ORIONPHARM-এর ধারাবাহিক খবর): শেয়ার প্রতি একত্রিত NAV (পুনর্মূল্যায়ন উদ্বৃত্ত ব্যতীত) ছিল টাকা। 85.21 মার্চ 31, 2024 এবং টাকা 81.15 জুন 30, 2023 পর্যন্ত। শেয়ার প্রতি NAV (পুনর্মূল্যায়ন উদ্বৃত্ত সহ) ছিল টাকা। 31 মার্চ, 2024 তারিখে 93.01 এবং টাকা 30 জুন, 2023 অনুযায়ী 88.99। (শেষ)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 66306ae1edb49c4b754d7143
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.